Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEP1B | Q16820 | 1/20 | 0.47 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | GFER | P55789 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | MAP1LC3B | Q9GZQ8 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | F2 | P00734 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL29702850 | 1.00 | MEP1B (0.47) | MEP1BRAPGEF4ALDH1A1HPGDMAPT | |
| SCHEMBL29454656 | 0.98 | MEP1B (0.49) | MEP1BRAPGEF4ALDH1A1HPGDMAPT | |
| SCHEMBL26645 | 0.98 | MEP1B (0.49) | MEP1BRAPGEF4ALDH1A1HPGDMAPT | |
| SCHEMBL3105642 | 0.96 | MEP1B (0.47) | MEP1BRAPGEF4ALDH1A1HPGDMAPT | |
| SCHEMBL6918128 | 0.96 | MEP1B (0.47) | MEP1BRAPGEF4ALDH1A1HPGDMAPT | |
| Water SCHEMBL2695854 | 0.96 | MEP1B (0.47) | MEP1BRAPGEF4ALDH1A1HPGDMAPT | |
| SCHEMBL6915075 | 0.96 | MEP1B (0.47) | MEP1BRAPGEF4ALDH1A1HPGDMAPT | |
| Water SCHEMBL21412761 | 0.96 | MEP1B (0.47) | MEP1BRAPGEF4ALDH1A1HPGDMAPT | |
| SCHEMBL6909827 | 0.96 | MEP1B (0.47) | MEP1BRAPGEF4ALDH1A1HPGDMAPT | |
| SCHEMBL6908120 | 0.96 | MEP1B (0.47) | MEP1BRAPGEF4ALDH1A1HPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250268840-A1 | USE OF NANO-CARRIERS FOR DELIVERY OF ACTIVE AGENTS | LANDA LABS (2012) LTD. (IL) | 2025-08-28 | — | — | US | disclosed |
| US-20240082118-A1 | TOPICAL COMPOSITIONS AND METHODS OF PREPARING THE SAME | LANDA LABS (2012) LTD. (IL) | 2024-03-14 | — | — | US | disclosed |
| WO-2023091342-A1 | PRESERVATION SYSTEM FOR STABILIZING SPORE-FORMING MICROBIALS | PHIBRO ANIMAL HEALTH CORPORATION (US) | 2023-05-25 | — | — | WO | disclosed |
| US-20230151324-A1 | PRESERVATION SYSTEM FOR STABILIZING SPORE-FORMING MICROBIALS | PHIBRO ANIMAL HEALTH CORPORATION (US) | 2023-05-18 | — | — | US | disclosed |
| EP-1288213-B1 | PROCESS FOR PREPARING OPTICALLY ACTIVE 2- 6-(HYDROXY-METHYL)-1,3-DIOXAN-4-YL|ACETIC ACID DERIVATIVES | KANEKA CORP (JP) | 2006-11-29 | — | — | EP | disclosed |
| US-20060246557-A1 | Process for preparing optically active 2-[6-(hydroxy-methyl)-1,3-dioxan-4-yl] acetic acid derivatives | KANEKA CORPORATION (JP) | 2006-11-02 | — | — | US | disclosed |
| US-7094594-B2 | Process for preparing optically active 2-[6-(hydroxy-methyl)-1,3-dioxan-4-yl] acetic acid derivatives | KANEKA CORPORATION (JP) | 2006-08-22 | — | — | US | disclosed |
| US-20050080277-A1 | Process for preparing optically active 2-[6-(hydroxy-methyl)-1,3-dioxan-4-yl] acetic acid derivatives | KANEKA CORPORATION (JP) | 2005-04-14 | — | — | US | disclosed |
| EP-1288213-A1 | PROCESS FOR PREPARING OPTICALLY ACTIVE 2- 6-(HYDROXY-METHYL)-1,3-DIOXAN-4-YL]ACETIC ACID DERIVATIVES | KANEKA CORPORATION (JP) | 2003-03-05 | — | — | EP | disclosed |
| US-6101946-A | Microarray printing device including printing pins with flat tips and exterior channel and method of manufacture | TELECHEM INTERNATIONAL INC. (US) | 2000-08-15 | — | — | US | disclosed |
| US-4687593-A | MIXTURE OF 2-PHENYL ALKYL BENZENE SULFONATE AND ALKYLATED DIPHENYL ETHER SULFATE | MONSANTO COMPANY (US) | 1987-08-18 | — | — | US | disclosed |
| US-4645623-A | WATER SOLUBLE MIXTURE OF 2-PHENYL ALKYLBENZENE SULFONATES AND ALKYLATED DIPHENYL OXIDE SULFONATES | MONSANTO COMPANY (US) | 1987-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060246557-A1 | Process for preparing optically active 2-[6-(hydroxy-methyl)-1,3-dioxan-4-yl] acetic acid derivatives | HAAO, APEH, HPD | MEP1B 1690/4885RAPGEF4 2467/4885ALDH1A1 174/4885 |
| US-20050080277-A1 | Process for preparing optically active 2-[6-(hydroxy-methyl)-1,3-dioxan-4-yl] acetic acid derivatives | HAAO, APEH, HPD | MEP1B 2191/4885RAPGEF4 2425/4885ALDH1A1 207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.